跳至主要内容
临床试验/NCT02748070
NCT02748070已完成不适用

The Role of Perioperative Systemic Steroids in Patients With Chronic Rhinosinusitis Without Polyps (CRSsNP)

Stanford University1 个研究点 分布在 1 个国家目标入组 81 人开始时间: 2015年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
81
试验地点
1
主要终点
Lund Kennedy Endoscopy Score Over Time

研究概览

简要总结

While oral steroids have been shown to be effective in the management of patients with chronic rhinosinusitis with polyps, its role in treating chronic rhinosinusitis without polyps (CRSsNP) is ambiguous. Despite a lack of strong clinical evidence to suggest a benefit in this disease state, steroids are often prescribed as a component of post-operative care after sinus surgery for patients without polyps. Oral steroids carry with them significant adverse effects, and should be prescribed thoughtfully. The aims of this study are to determine if oral steroids in the peri-operative period improves patient outcomes in CRS without polyps.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • CRSsNP as defined by Clinical Practice Guideline (Update) on Adult Sinusitis
  • scheduled to undergo endoscopic sinus surgery

排除标准

  • chronic rhinosinusitis with polyps (CRSwNP)
  • Aspirin exacerbated respiratory disease
  • Cystic fibrosis
  • Immunosuppressive states (Human immunodeficiency virus, transplant)
  • Oral steroid use within 30 days of surgery

研究组 & 干预措施

Prednisone

Experimental

Provided oral steroid and topical steroid

干预措施: Flonase (Drug)

Placebo

Placebo Comparator

Provided oral placebo and topical steroid

干预措施: Flonase (Drug)

Prednisone

Experimental

Provided oral steroid and topical steroid

干预措施: Prednisone (Drug)

结局指标

主要结局

Lund Kennedy Endoscopy Score Over Time

时间窗: Baseline, 1, week, 1 month, 3 months, and 6 months

The Lund-Kennedy score is a validated scale by which clinicians grade the endoscopic appearance of the sinonasal cavity for sinusitis patients. There are 5 parameters rated on a scale of 0-2 for each side of the nose, for a maximum total score of 20 points. Higher scores represent a worse endoscopic appearance.

Sino-nasal Outcome Test (SNOT-22) Over Time

时间窗: Baseline, 1, week, 1 month, 3 months, and 6 months

SNOT-22 is a validated scale which measures sinonasal symptoms for sinusitis patients. The 22 questions are rated on a scale of 0-5 for a maximum total score of 110. Higher scores represent more symptomatic patients.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Julia Noel

Principal Investigator

Stanford University

研究点 (1)

Loading locations...

相似试验

Perioperative Oral Steroids for Chronic... | 临床试验